Iradimed (IRMD) Return on Capital Employed (2014 - 2026)

Iradimed (IRMD) has 13 years of Return on Capital Employed data on file, last reported at 7.8% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 7.8%, down 1693.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.8% (down 1693.0% YoY), and the FY2025 annual result was 6.38%, down 1895.0% from the prior year.
• Return on Capital Employed climbed to 7.8% in Q1 2026 per IRMD's latest filing, from 5.86% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 27.28% in Q4 2023 and troughed at 5.86% in Q4 2025.
• A 5-year average of 21.56% and a median of 24.74% in 2025 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2022 and 2025: Return on Capital Employed jumped 1515 bps in 2022, then slumped 1916 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 21.13% in 2022, then increased by 29 bps to 27.28% in 2023, then slipped by 8 bps to 25.02% in 2024, then plunged by 77 bps to 5.86% in 2025, then soared by 33 bps to 7.8% in 2026.
• Business Quant data shows IRMD's Return on Capital Employed at 7.8% in Q1 2026, 5.86% in Q4 2025, and 25.42% in Q3 2025.